دانلود مقالات ISI درباره Certolizumab Pegol + ترجمه فارسی

اظهارات اجماعی برای عمل جراحی: عوامل بیولوژیکی و بیماری ریه [ترجمه انگلیسی به انگلیسی توسط انجمن تنفسی ژاپنی]

Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]

Keywords: MTX; methotrexate; TNF; tumor necrosis factor; IL; interleukin; CTLA4; cytotoxic T-lymphocyte antigen 4; IFX; infliximab; ADA; adalimumab; GLM; golimumab; CZP; certolizumab pegol; ETN; etanercept; TCZ; tocilizumab; ABA; abatacept; RTX; rituximab; UTK; ust

دانلود رایگان متن کامل مقاله ISI 23 صفحه سال انتشار : 2017 سفارش ترجمه

اثربخشی و ایمنی آنتاگونیستهای عامل ناکروز تومور در سارکوئیدوز مقاوم به: یک مطالعه چند مرکزی در 132 بیمار

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

Keywords: ADA; adalimumab; AEs; adverse events; AZA; azathioprine; CI; confidence interval; Cy; cyclosporine; CNS; central nervous system; CS; corticosteroids; CYC; cyclophosphamide; CZP; certolizumab pegol; ePOST; Extrapulmonary Physician Organ Severity Tool; ETN;

دانلود رایگان متن کامل مقاله ISI 27 صفحه سال انتشار : 2017 سفارش ترجمه

هدف قرار دادن التهاب در جلوگیری از بیماری قلبی عروقی در بیماران مبتلا به آرتروز التهابی

Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis

Keywords: ABA; abatacept; ADA; adalimumab; AIx; augmentation index; AMI; acute myocardial infarction; ANA; anakinra; Apo; apolipoprotein; AS; ankylosing spondylitis; CTZ; certolizumab pegol; CV; cardiovascular; CVD; cardiovascular disease; DMARD; disease-modifying

دانلود رایگان متن کامل مقاله ISI 14 صفحه سال انتشار : 2016 سفارش ترجمه

میزان انطباق و طولانی مدت قطع درمان های بیولوژیک در کولیت اولسراتیو

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis

Keywords: Ulcerative colitis; Infliximab; Adalimumab; Certolizumab pegol; Appropriateness; Treatment discontinuation;

دانلود رایگان متن کامل مقاله ISI 10 صفحه سال انتشار : 2014 سفارش ترجمه

مقایسه اثربخشی درمان بیولوژیک در بیماران مبتلا به بیماری کرون ناخوشایی زیستی: بررسی منظم و متاآنالیز شبکه

Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysis

Keywords: ADA; adalimumab; CD; Crohn disease; CDAI; Crohn's Disease Activity Index; CrI; credible interval; CZP; certolizumab pegol; HR; hazard ratio; IBD; inflammatory bowel disease; IFX; infliximab; IL-12/23; interleukin 12/23; NAT; natalizumab; OR; odds ratio;

دانلود رایگان متن کامل مقاله ISI 15 صفحه سال انتشار : 2014 سفارش ترجمه

بازنشستگی بیمار و بازنشستگی معلولیت در بیماری التهابی روده: یک بررسی سیستماتیک

Sick leave and disability pension in inflammatory bowel disease: A systematic review

Keywords: A; absenteeism; ADA; adalimumab; CD; Crohn's disease; CPC; conventional proctocolectomy and Brooke ileostomy; CZP; certolizumab pegol; HPWAW; hours per week actually worked; HPWFP; productivity and hours per week fully productive; IBD; inflammatory bowel

دانلود رایگان متن کامل مقاله ISI 16 صفحه سال انتشار : 2014 سفارش ترجمه

رویدادهای متفرقه دیگر با عوامل بیولوژیک (شامل عفونت و بدخیمی)

Miscellaneous Adverse Events with Biologic Agents (Excludes Infection and Malignancy)

Keywords: Anti-tumor necrosis factor; Infliximab; Adalimumab; Golimumab; Certolizumab pegol; Complications; Infusion reactions; Autoimmune disease;

دانلود رایگان متن کامل مقاله ISI 21 صفحه سال انتشار : 2014 سفارش ترجمه

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

Keywords: Adalimumab; Certolizumab pegol; Etanercept; Golimumab; Infection; Infliximab; Prevention; Tuberculosis; Tumour necrosis factor-α;

دانلود رایگان متن کامل مقاله ISI 11 صفحه سال انتشار : 2018 سفارش ترجمه

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)

Keywords: anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPASI-1; CIMPASI-2; phase 3 trial; CZP; certolizumab pegol; DLQI; Dermatology Life Quality Index; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index;

دانلود رایگان متن کامل مقاله ISI 35 صفحه سال انتشار : 2018 سفارش ترجمه

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)

Keywords: anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPACT; etanercept; phase 3 trial; CZP; certolizumab pegol; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index; PASI 50; ≥50% reduction in PASI from

دانلود رایگان متن کامل مقاله ISI 36 صفحه سال انتشار : 2018 سفارش ترجمه

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

Keywords: Crohn's Disease; Biologics; Pharmacokinetics; Serum Drug Level; ADA; antidrug antibodies; CD; Crohn's disease; CI; confidence interval; CZP; certolizumab pegol; ELISA; enzyme-linked immunosorbent assay; HMSA; homogenous mobility shift assay; IBD; infl

دانلود رایگان متن کامل مقاله ISI 53 صفحه سال انتشار : 2017 سفارش ترجمه

Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer

Keywords: Anti-TNF; Certolizumab pegol; Fc receptor; Immunoglobulin transport; Materno-fetal transfer;

دانلود رایگان متن کامل مقاله ISI 6 صفحه سال انتشار : 2016 سفارش ترجمه

Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease

Keywords: Biologics; Real-World Effectiveness; Database Analysis; Propensity Matching; ADA; adalimumab; aHR; adjusted hazard ratio; CD; Crohn's disease; CI; confidence interval; CZP; certolizumab pegol; IBD; inflammatory bowel disease; ICD-9; International Classi

دانلود رایگان متن کامل مقاله ISI 54 صفحه سال انتشار : 2016 سفارش ترجمه

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease

Keywords: CDAI; MUSIC Trial; PK Study; TNF Inhibitor; BMI; body mass index; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CI; confidence interval; CRP; C-reactive protein; CZP; certolizumab pegol; MU

دانلود رایگان متن کامل مقاله ISI 10 صفحه سال انتشار : 2014 سفارش ترجمه

Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease

Keywords: Anti-tumor necrosis factor; Infliximab; Adalimumab; Certolizumab pegol; Crohn disease;

دانلود رایگان متن کامل مقاله ISI 22 صفحه سال انتشار : 2014 سفارش ترجمه

American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

Keywords: ACG; American College of Gastroenterology; ADA; adalimumab; AZA; azathioprine; BSG; British Society of Gastroenterology; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CZP; certolizumab pegol; ECCO; European Crohn's an

دانلود رایگان متن کامل مقاله ISI 20 صفحه سال انتشار : 2013 سفارش ترجمه

Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

Keywords: Ulcerative Colitis; Crohn's Disease; Treatment; Safety; Pregnancy; ADA; adalimumab; BCG; bacillus Calmette-Guérin; CZP; certolizumab pegol; ELISA; enzyme-linked immunosorbent assay; IBD; inflammatory bowel disease; IFX; infliximab; Ig; immunoglobulin;

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2013 سفارش ترجمه

Certolizumab pegol

Keywords: Artritis reumatoide; Anti-TNF; Certolizumab pegol; Eficacia; Seguridad; Daño estructuralRheumatoid arthritis; Anti-TNF; Certolizumab pegol; Efficacy; Safety; Structural damage

دانلود رایگان متن کامل مقاله ISI 5 صفحه سال انتشار : 2011 سفارش ترجمه

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study

Keywords: Anti-TNF Inhibitor; Relapsed Crohn's Disease; Certolizumab Pegol; PRECiSE 4; CDAI; Crohn's Disease Activity Index; HBI; Harvey-Bradshaw Index; PRECiSE; Pegylated Antibody Fragment Evaluation in Crohn's Disease: Safety and Efficacy; TNF; tumor necrosis f

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2010 سفارش ترجمه

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab

Keywords: Crohn's Disease; Anti-TNF; Certolizumab Pegol; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein; IBDQ; Inflammatory Bowel Disease Questionnaire; TNF-α; tumor necrosis factor-α;

دانلود رایگان متن کامل مقاله ISI 10 صفحه سال انتشار : 2010 سفارش ترجمه

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Keywords: Certolizumab Pegol; Crohn's Disease; Anti-Tumor Necrosis Factor α; AE; adverse event; anti-dsDNA; anti-double-stranded DNA antibodies; ANAs; antinuclear antibodies; CDAI; Crohn's Disease Activity Index; HBI; Harvey-Bradshaw Index; PRECiSE; PEGylate

دانلود رایگان متن کامل مقاله ISI 10 صفحه سال انتشار : 2010 سفارش ترجمه

Special ArticleReport of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

Keywords: mAbs; monoclonal antibodies; IFX; infliximab; ADA; adalimumab; CZP; Certolizumab pegol; PNR; primary non response to anti-TNF agent; LOR; loss of response to anti-TNF agent; ATI; antibodies to infliximab; ATA; antibodies to adalimumab; FcγR; Fc gamma rec

دانلود رایگان متن کامل مقاله ISI 12 صفحه سال انتشار : 2010 سفارش ترجمه

Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology

Keywords: Tumor necrosis factor-α; Infliximab; Adalimumab; Certolizumab pegol; Crohn disease; Ulcerative colitis;

دانلود رایگان متن کامل مقاله ISI 15 صفحه سال انتشار : 2010 سفارش ترجمه

Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

Keywords: ADA; adalimumab; CD; Crohn's disease; CI; confidence interval; CTZ; certolizumab pegol; IFX; infliximab; 6MP; 6-mercaptopurine; NHL; non-Hodgkin's lymphoma; RCT; randomized controlled trial; SD; standard deviation; SEER; Surveillance, Epidemiology & End R

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2009 سفارش ترجمه

Serum sickness, encephalitis and other complications of anti-cytokine therapy

Keywords: anti-TNF therapy; infliximab; adalimumab; certolizumab pegol; natalizumab; safety; immunogenicity; progressive multifocal leucoencephalopathy

دانلود رایگان متن کامل مقاله ISI 12 صفحه سال انتشار : 2009 سفارش ترجمه